
Sign up to save your podcasts
Or


A JAMA paper suggests that in all but the most severe exacerbations of COPD, it’s best to start off with low-dose oral corticosteroids rather than the higher-dose intravenous treatment that, contrary to guideline recommendations, almost everyone now gets. Our conversation this week is with the study’s first author, Dr. Peter Lindenauer.
Visit the Journal Watch website at http://jwatch.org for a comprehensive look at new medical research, with comments from our experts.
Interview-related links:
News-related links:
By NEJM Group4.5
5656 ratings
A JAMA paper suggests that in all but the most severe exacerbations of COPD, it’s best to start off with low-dose oral corticosteroids rather than the higher-dose intravenous treatment that, contrary to guideline recommendations, almost everyone now gets. Our conversation this week is with the study’s first author, Dr. Peter Lindenauer.
Visit the Journal Watch website at http://jwatch.org for a comprehensive look at new medical research, with comments from our experts.
Interview-related links:
News-related links:

7,709 Listeners

317 Listeners

2,061 Listeners

125 Listeners

498 Listeners

299 Listeners

883 Listeners

259 Listeners

3,348 Listeners

112,401 Listeners

92 Listeners

5 Listeners

92 Listeners

515 Listeners

2,548 Listeners

367 Listeners

16,010 Listeners

60 Listeners

31 Listeners

66 Listeners